FDA proposes off-label communication norms for medical products

Jan 18 (Reuters) - The U.S. health regulator issued draft

guidance for promotional materials and data not on the label of

medical products, recommending manufacturers characterize

relevant information, including disclosing unfavorable or

inconsistent findings.

Read more